Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
Abstract As evidence is inconsistent and based on either isolated Asian or Western studies, we conducted a network meta-analysis (NMA) to examine efficacy and safety of 5-FU (5-fluorouracil), capecitabine and S-1-based first-line treatment of advanced esophagogastric cancer in Asian and Western pati...
Main Authors: | Emil ter Veer, Lok Lam Ngai, Gert van Valkenhoef, Nadia Haj Mohammad, Maarten C. J. Anderegg, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-07750-3 |
Similar Items
-
The Use of (Network) Meta-Analysis in Clinical Oncology
by: Emil ter Veer, et al.
Published: (2019-08-01) -
Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy
by: Uğur Nadir Karakulak, et al.
Published: (2016-02-01) -
A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine
by: Michael Chahin, et al.
Published: (2020-01-01) -
COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis
by: Tom van den Ende, et al.
Published: (2019-07-01) -
Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01)